[使用DX进行造血干细胞移植的未来]
1Division of Medical Informatics, Wakayama Medical University Hospital.
概括
信息和通信技术 (ICT) 和数字化转型 (DX) 正在彻底改变造血干细胞移植. 这些进步增强了数据分析,使远程医疗成为可能,并改善了患者的护理和结果.
科学领域:
- 生物医学信息学 生物医学信息学
- 移植医学 移植医学
- 数字健康数字健康
背景情况:
- 造血干细胞移植 (HSCT) 是一个复杂的医疗程序,具有重大后勤和数据管理挑战.
- 信息和通信技术 (ICT) 的日益集成为优化高科技的各个方面提供了机会.
- 数字化转型 (DX) 在HSCT中为数据处理,患者监控和服务提供提供了潜在的解决方案.
研究的目的:
- 探索ICT和DX对造血干细胞移植的影响.
- 突出数字工具如何改善HSCT的数据管理,患者护理和可访问性.
- 讨论这些技术进步对HSCT未来的影响.
主要方法:
- 审查ICT在高科技技术中的当前应用.
- 分析数字化转型如何促进数据收集,分析和远程医疗.
- 检查电子医疗记录和可穿戴设备在个性化医疗中的作用.
- 评估在线咨询和患者报告的结果在HSCT后续和管理.
主要成果:
- ICT和DX简化了医疗数据收集和分析在HSCT.
- 远程医疗扩展了医疗服务超越了地理限制,改善了获得护理的机会.
- 电子医疗记录和可穿戴设备支持个性化医疗和疾病预测.
- 在线咨询增强了移植后的随访,捐赠者招募和查,特别是在农村地区.
- 患者报告的结果有助于改善治疗结果和患者管理.
结论:
- 在HSCT的数字化转型改善了治疗结果,护理质量和患者便利性.
- 提高医疗保健专业人员和患者的IT素养对于有效利用ICT至关重要.
- 信息通信技术和DX正在为HSCT的创新未来医疗保健模式铺平道路.
相关概念视频
Bone Marrow Sampling and Transplants
324
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
324
Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Multipotency of Hematopoietic Stem Cells
3.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.1K
iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K


